MGRC | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

7
0.815 (0.62%)

T-O: 0.815 (08:59:00)
Last updated: 17:00

Fundamental
Technical
Total Score

MGRC | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

iSaham Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Quarter Reports

Chart:

Trailing Dividend

Financial Ratios

EPS0.89 sen
Trailing PE (Sector Median: 13.4)91.2
PEG0.91
Altman Z0.9
Beaver0.096
Current Ratio29.03
Debt-Equity (DE) Ratio0.06
FCF Yield-0.75 %
Revenue QoQ212.22 %
Revenue YoY1084.36 %
Profit QoQ882.0 %
Profit YoY114.53 %
Profit Margin (Sector Median: 9.6)5.05 %
ROE (ROIC: 3.35)3.35 %
Dividend Per Share (DPS)0.0 sen
Dividend Yield (DY)0.0 %

Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Graham Formula
Graham Number
Net Tangible Asset (NTA)27.0
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M]1.96
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M)0.0
Expected Revenue (M)0.0
Expected Growth (%)0.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

Directors Share Purchases (Beta)


ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 120000.0 units announced on 08 Jun 2022 at ~RM0.63

DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 694000.0 units announced on 16 Jul 2021 at ~RM1.56

DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 851679.0 units announced on 24 Feb 2021 at ~RM1.19

TAN SRI DATUK DR RAFIAH BINTI SALIM added 10000.0 units announced on 10 Feb 2021 at ~RM0.88

DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 354070.0 units announced on 07 Jan 2021 at ~RM1.05

TAN SRI DATUK DR RAFIAH BINTI SALIM added 20000.0 units announced on 24 Dec 2020 at ~RM0.885

TAN SRI DATUK DR RAFIAH BINTI SALIM added 10000.0 units announced on 22 Dec 2020 at ~RM0.83

TAN SRI DATUK DR RAFIAH BINTI SALIM added 60000.0 units announced on 16 Dec 2020 at ~RM0.78

Summary


Market Cap: 101 M.

Number of Shares: 124 M.

Adjusted Float: 83.8%.

Stock highly correlated with

GREATEC (81%)

GESHEN (80%)

KARYON (80%)

FITTERS (78%)

MGRC provides genome sequencing and analysis services. Our services and pipelines are designed to rapidly sequence and analyse large volumes of genetic data and extract meaningful biological information for downstream research and development. The key components of our commercial operations are our Contract Genomics Services, Sequencing Services, and Data and Access Services. Our services and applications have been used extensively in significant projects, including the mapping of the lung cancer genome, and the sequencing and assembly of the oil palm genome. To date, the company have undertaken projects for large agriculture-based companies, major medical research institutions, and government linked or funded entities in Malaysia and abroad, including United States and Australia. Currently, MGRC are the only player in Malaysia providing commercial bioinformatics analysis services for data from multiple second and third generation sequencing machines, serving public and private sector organizations in Malaysia and internationally. They have established themselves as Malaysia's leading provider of Contract Genomics Services

Sectors: Healthcare, Health Care Equipment & Services

Code: 0155

Website: http://www.mgrc.com.my/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

Top Shareholdings

Updated on 30-Sep-2021

ShareholderValue (M)
Phillip Securities (Hong Kong) Ltd8.39
Liw Chai Yuk7.96
Pixelvest Sdn Bhd4.99
Chu Boon Lin4.07
Goh Bian Soon2.86
Kevin Tan Yean Khim2.69
Saw Sooi Huat2.57
Wong Wee Yong2.17
Yeo Tsu Sin2.13
Ping Hiow Yew1.81
Mohd Rafael bin Mohd Shamsudin1.8
Munirah binti Haji Abdul Hamid1.79
Ooi Cyndy1.58
Barclays Capital Securities Ltd1.4
Ong San Leong1.21
Liong Liuh Juin1.14
Wong Chen How1.12
Nor Azah binti Adnan1.06
Foo Chai Lee1.0
Albert Tan Yean Heong0.98
Inertia Aif Sdn Bhd0.96
Noraziah binti Adnan0.94
Khoo Hai Chew0.82
Shahril bin Shamsuddin0.82
Societe Generale Paris0.79
Choong Chee Yip0.68
Tan Kok Aun0.67

This calculator use Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator use Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.